NCT06634524View on ClinicalTrials.gov

Effect of Dexmedetomidine on Gastric Emptying, Assessed by Ultrasound in Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 12, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
DexmedetomidineGastric EmptyingUltrasoundLaparoscopic Cholecystectomy
Interventions
DRUG

Dexmeditomidine

Patients who will receive IV infusion of (0.2 µg/kg/hr dexmeditomidine).

DRUG

Normal saline

Patients who will receive IV infusion of normal saline, at the same rate of dexmedetomidine infusion.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06634524 - Effect of Dexmedetomidine on Gastric Emptying, Assessed by Ultrasound in Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter